Utilization of Corn Cob Hemicellulose in Swelling Tablet Formulations as a Novel Approach of Dietary Therapy. JURNAL FARMASIMED (JFM), [S. l.], v. 9, n. 1, p. 1068–1074, 2026. DOI: 10.35451/jfm.v9i1.4075. Disponível em: https://ejournal.medistra.ac.id/index.php/JFM/article/view/4075. Acesso em: 1 nov. 2026.